CATRINA CERASANI: Open Payments
NPI 1669186474 · CLARK, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$377 in 19 payments from 14 companies in 2025. Trend: 2023 $0 · 2024 $445 · 2025 $377
Food & beverage: $377
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 5 | $110 |
| Cumberland Pharmaceuticals, Inc. | 2 | $36 |
| Biogen, Inc. | 1 | $25 |
| Hologic Sales and Service, LLC | 1 | $23 |
| Exact Sciences Corporation | 1 | $22 |
| GlaxoSmithKline, LLC. | 1 | $20 |
| Neurocrine BioSciences, Inc. | 1 | $20 |
| Aspira Women's Health Inc | 1 | $19 |
| Merck Sharp & Dohme LLC | 1 | $19 |
| MILLICENT US INC | 1 | $18 |
Products named: Veozah, SANCUSO, TYSABRI, APTIMA, Cologuard Collection Kit, JEMPERLI, INGREZZA, OVA1.
Industry payments across NJ — which companies pay providers there.
